Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab.
Yano S, Kawaoka T, Johira Y, Miura R, Kosaka M, Shirane Y, Murakami S, Amioka K, Naruto K, Ando Y, Kosaka Y, Yamaoka K, Kodama K, Uchikawa S, Fujino H, Ohno A, Nakahara T, Murakami E, Okamoto W, Yamauchi M, Imamura M, Mori K, Arihiro K, Kuroda S, Kobayashi T, Ohdan H, Aikata H.
Yano S, et al. Among authors: kuroda s.
Medicine (Baltimore). 2021 Oct 22;100(42):e27576. doi: 10.1097/MD.0000000000027576.
Medicine (Baltimore). 2021.
PMID: 34678902
Free PMC article.